Back to MW Marshall Wace, LLP
PRTA
Showing 3 of 16 quarters
Position history for MWMarshall Wace, LLP's holdings in Prothena Corporation plc
Yes. Marshall Wace holds 190,834 shares of PRTA (Prothena), worth $1.9M, as of its Q2 2026 13F filing. It increased the position from 44,574 shares in Q1 2026. Marshall Wace has held PRTA since Q4 2025, across 3 quarterly 13F filings.
Current Value
$1.9M
Current Shares
190,834
Total Value Change
+$1.3M
Total Shares Change
+136,056
Quarter-by-Quarter History